Management Strategies for Patients With Atrial Fibrillation-Related Ischemic Stroke Despite Oral Anticoagulation
Circulation Journal · 2025
DOI: 10.1253/circj.cj-25-0678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Journal, 2025. Verfasst von Ryuki Chatani und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kurashiki Central Hospital. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Ischemic Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: In patients with atrial fibrillation-related ischemic stroke despite oral anticoagulation (AFIDA), left atrial appendage closure (LAAC) may be an additional strategy to prevent further stroke events. METHODS AND RESULTS: AFIDA was defined as ischemic stroke occurring despite ≥3 weeks of oral anticoagulation (OAC). We evaluated patients with AFIDA treated either with OAC alone (n=141; further divided into aggressive OAC [n=73] and conventional OAC [n=68] subgroups) or with additional LAAC (+LAAC; n=95; further divided into continued OAC [n=44] and discontinued OAC within 1 year after LAAC [n=51] subgroups). Patients in the +LAAC group were younger, had higher HAS-BLED scores, and lower HELT-E2S2scores. Three-year cumulative incidence rates of ischemic stroke and major bleeding were comparable between the OAC alone and +LAAC groups (15.2% vs. 14.5% [log-rank P=0.75] and 23.4% vs. 5.3% [log-rank P=0.38], respectively), whereas those of fatal or disabling stroke and fatal bleeding were lower in the +LAAC than OAC alone group (3.4% vs. 14.7% [log-rank P=0.06] and 0% vs. 6.0% [log-rank P=0.03], respectively). Results of propensity score-matched and subgroup analyses were largely consistent with those of the main analysis. Notably, fatal bleeding occurred only in patients switched to aggressive OAC. CONCLUSIONS: LAAC may potentially prevent fatal or disabling stroke and fatal bleeding in patients with AFIDA. These hypothesis-generating findings support the need for randomized controlled trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Kurashiki Central Hospital.
- Department of Neurosurgery, Kurashiki Central Hospital.
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
Zitieren
APA
Chatani, R., Kinosada, M., Kaneda, K., Yamashita, Y., Harata, H., Fujita, M., Nishiura, N., Mushiake, K., Ono, S., Tasaka, H., Maruo, T., Kadota, K., Chin, M., & Kubo, S. (2025). Management Strategies for Patients With Atrial Fibrillation-Related Ischemic Stroke Despite Oral Anticoagulation. Circulation Journal. https://doi.org/10.1253/circj.cj-25-0678
Vancouver
Chatani R, Kinosada M, Kaneda K, Yamashita Y, Harata H, Fujita M, et al. Management Strategies for Patients With Atrial Fibrillation-Related Ischemic Stroke Despite Oral Anticoagulation. Circulation Journal. 2025. doi:10.1253/circj.cj-25-0678
BibTeX
@article{Chatani2025,
author = {Chatani, Ryuki and Kinosada, Masanori and Kaneda, Kazuhisa and Yamashita, Yugo and Harata, Haruka and Fujita, Mikitaka and Nishiura, Naoki and Mushiake, Kazunori and Ono, Sachiyo and Tasaka, Hiroshi and Maruo, Takeshi and Kadota, Kazushige and Chin, Masaki and Kubo, Shunsuke},
title = {Management Strategies for Patients With Atrial Fibrillation-Related Ischemic Stroke Despite Oral Anticoagulation},
journal = {Circulation Journal},
year = {2025},
doi = {10.1253/circj.cj-25-0678}
}
EUVIMED